Zobrazeno 1 - 10
of 16 282
pro vyhledávání: '"Sagi, D."'
Autor:
Byrne, Peter
Publikováno v:
Religious Studies, 1996 Sep 01. 32(3), 424-425.
Externí odkaz:
https://www.jstor.org/stable/20019836
Autor:
Kahalani-Hodedany, Ravit1 (AUTHOR), Lev, Maria1 (AUTHOR), Sagi, Dov2 (AUTHOR), Polat, Uri1 (AUTHOR) uri.polat@biu.ac.il
Publikováno v:
Scientific Reports. 10/19/2024, Vol. 14 Issue 1, p1-10. 10p.
Autor:
Bell, Lucy C.K., Meydan, Cem, Kim, Jacob, Foox, Jonathan, Butler, Daniel, Mason, Christopher E., Shapira, Sagi D., Noursadeghi, Mahdad, Pollara, Gabriele
Publikováno v:
In iScience 22 January 2021 24(1)
Single-Cell Profiling Uncovers Evolutionary Divergence of Hypocretin/Orexin Neuronal Subpopulations.
Autor:
Sagi D; The Faculty of Life Sciences and The Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 590002, Israel., Tibi M; The Faculty of Biotechnology and Food Engineering, Technion 3200, Israel., Admati I; The Faculty of Biotechnology and Food Engineering, Technion 3200, Israel., Lerer-Goldshtein T; The Faculty of Life Sciences and The Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 590002, Israel., Hochgerner H; The Faculty of Biotechnology and Food Engineering, Technion 3200, Israel., Zeisel A; The Faculty of Biotechnology and Food Engineering, Technion 3200, Israel., Appelbaum L; The Faculty of Life Sciences and The Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 590002, Israel lior.appelbaum@biu.ac.il.
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2024 Sep 04; Vol. 44 (36). Date of Electronic Publication: 2024 Sep 04.
Autor:
Oberstein PE; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Kawaler EA; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York., Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Beri N; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Bollenrucher N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chang E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Dolgalev I; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Werba G; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York., Lima C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Keheler CE; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Sullivan KM; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Dougan M; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Hajdu C; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Pathology, NYU Langone Health, New York, New York., Dajee M; Novartis Institute for Biomedical Research, Cambridge, Massachusetts., Pelletier MR; Novartis Institute for Biomedical Research, Cambridge, Massachusetts., Nazeer S; Novartis Pharmaceuticals, Cambridge, Massachusetts., Squires M; Novartis Pharmaceuticals, Cambridge, Massachusetts., Bar-Sagi D; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Simeone DM; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1221-1235.
Autor:
Levkovich G; Department of Poultry and Aquaculture, Institute of Animal Science, Agricultural Research Organization, Volcani Institute, Rishon LeZion, Israel.; The Mina and Everard Goodman Faculty of Life Sciences, The Sagol Center for Healthy Human Longevity, Bar-Ilan University, Ramat Gan, Israel., Shmulevitch R; Lab For Precision Livestock Farming (PLF), Agricultural Engineering Institute, Volcani Institute, Rishon LeZion, Israel.; Industrial Engineering & Management (IEM) Department, Faculty of Engineering Sciences, Ben-Gurion University, Be'er Sheva, Israel., Almagor D; Hebrew University of Jerusalem Koret School of Veterinary Medicine, Rehovot, Israel., Reshef L; Lab For Precision Livestock Farming (PLF), Agricultural Engineering Institute, Volcani Institute, Rishon LeZion, Israel., Shiklov G; Department of Poultry and Aquaculture, Institute of Animal Science, Agricultural Research Organization, Volcani Institute, Rishon LeZion, Israel.; The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel., Rusal M; Department of Poultry and Aquaculture, Institute of Animal Science, Agricultural Research Organization, Volcani Institute, Rishon LeZion, Israel., Halachmi I; Lab For Precision Livestock Farming (PLF), Agricultural Engineering Institute, Volcani Institute, Rishon LeZion, Israel., Sagi D; Department of Poultry and Aquaculture, Institute of Animal Science, Agricultural Research Organization, Volcani Institute, Rishon LeZion, Israel. dror.sagi@mail.huji.ac.il.
Publikováno v:
Scientific reports [Sci Rep] 2024 Aug 13; Vol. 14 (1), pp. 18780. Date of Electronic Publication: 2024 Aug 13.
Corrigendum to "Motion-induced blindness as a noisy excitable system" [Vis. Res. 216 (2024) 108363].
Autor:
Katkov M; Department of Brain Sciences, The Weizmann Institute of Science, Rehovot, Israel. Electronic address: mikhail.katkov@gmail.com., Meital-Kfir N; Department of Brain Sciences, The Weizmann Institute of Science, Rehovot, Israel., Sagi D; Department of Brain Sciences, The Weizmann Institute of Science, Rehovot, Israel.
Publikováno v:
Vision research [Vision Res] 2024 Aug; Vol. 221, pp. 108415. Date of Electronic Publication: 2024 May 07.
Autor:
Thomas J. Liesegang
Publikováno v:
American Journal of Ophthalmology. 134:155-156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c8596f5cab31e37807968e86fe1b158
https://doi.org/10.1016/s0002-9394(02)01555-6
https://doi.org/10.1016/s0002-9394(02)01555-6
Autor:
Lucy C.K. Bell, Cem Meydan, Jacob Kim, Jonathan Foox, Daniel Butler, Christopher E. Mason, Sagi D. Shapira, Mahdad Noursadeghi, Gabriele Pollara
Publikováno v:
iScience, Vol 24, Iss 1, Pp 101896- (2021)
Summary: Dysregulated IL-1β and IL-6 responses have been implicated in the pathogenesis of severe Coronavirus Disease 2019 (COVID-19). Innovative approaches for evaluating the biological activity of these cytokines in vivo are urgently needed to com
Externí odkaz:
https://doaj.org/article/8ebe48f1fdef4850846e6654ad7d6bc1
We investigate the final stage of cytokinesis in two types of amoeba, pointing out the existence of biphasic furrow contraction. The first phase is characterized by a constant contraction rate, is better studied, and seems universal to a large extent
Externí odkaz:
http://arxiv.org/abs/q-bio/0310016
